These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15542977)

  • 1. Meningioma: an update.
    Lusis E; Gutmann DH
    Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.
    Choy W; Kim W; Nagasawa D; Stramotas S; Yew A; Gopen Q; Parsa AT; Yang I
    Neurosurg Focus; 2011 May; 30(5):E6. PubMed ID: 21529177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics of meningiomas: from basic research to potential clinical applications.
    Simon M; Boström JP; Hartmann C
    Neurosurgery; 2007 May; 60(5):787-98; discussion 787-98. PubMed ID: 17460514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of meningiomas.
    Ragel BT; Jensen RL
    Neurosurg Focus; 2005 Nov; 19(5):E9. PubMed ID: 16398473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic landscape of intracranial meningiomas.
    Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
    J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression.
    Simon M; Park TW; Leuenroth S; Hans VH; Löning T; Schramm J
    J Neurosurg; 2000 May; 92(5):832-40. PubMed ID: 10794298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
    Peyre M; Stemmer-Rachamimov A; Clermont-Taranchon E; Quentin S; El-Taraya N; Walczak C; Volk A; Niwa-Kawakita M; Karboul N; Giovannini M; Kalamarides M
    Oncogene; 2013 Sep; 32(36):4264-72. PubMed ID: 23045274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal cytogenetic progression within intratumorally heterogeneous meningiomas predicts tumor recurrence.
    Urbschat S; Rahnenführer J; Henn W; Feiden W; Wemmert S; Linsler S; Zang KD; Oertel J; Ketter R
    Int J Oncol; 2011 Dec; 39(6):1601-8. PubMed ID: 21922133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.
    Beauchamp RL; James MF; DeSouza PA; Wagh V; Zhao WN; Jordan JT; Stemmer-Rachamimov A; Plotkin SR; Gusella JF; Haggarty SJ; Ramesh V
    Oncotarget; 2015 Jul; 6(19):16981-97. PubMed ID: 26219339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Practical Overview on the Molecular Biology of Meningioma.
    Delgado-López PD; Cubo-Delgado E; González-Bernal JJ; Martín-Alonso J
    Curr Neurol Neurosci Rep; 2020 Nov; 20(12):62. PubMed ID: 33136206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms.
    Pham MH; Zada G; Mosich GM; Chen TC; Giannotta SL; Wang K; Mack WJ
    Neurosurg Focus; 2011 May; 30(5):E7. PubMed ID: 21529178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas.
    Yew A; Trang A; Nagasawa DT; Spasic M; Choy W; Garcia HM; Yang I
    J Clin Neurosci; 2013 Jan; 20(1):17-22. PubMed ID: 22743042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse.
    Espinosa AB; Tabernero MD; Maíllo A; Sayagués JM; Ciudad J; Merino M; Alguero MC; Lubombo AM; Sousa P; Santos-Briz A; Orfao A
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):772-80. PubMed ID: 16467088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of meningiomas.
    McDermott MW
    Curr Opin Neurol; 1996 Dec; 9(6):409-13. PubMed ID: 9007396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases.
    Zang KD
    Cytogenet Cell Genet; 2001; 93(3-4):207-20. PubMed ID: 11528114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MOLECULAR PATHOLOGY OF MENINGIOMAS].
    Murnyák B; Csonka T; Hortobágyi T
    Ideggyogy Sz; 2015 Sep; 68(9-10):292-300. PubMed ID: 26665490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alterations in meningioma: prognostic and therapeutic perspectives.
    Birzu C; Peyre M; Sahm F
    Curr Opin Oncol; 2020 Nov; 32(6):613-622. PubMed ID: 32890025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma.
    Ozaki S; Nishizaki T; Ito H; Sasaki K
    J Neurooncol; 1999 Jan; 41(2):167-74. PubMed ID: 10222437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.